Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediteknology is an Italian biotechnology company and a spin-off from the University of Salento, specializing in advanced nanotechnology for drug delivery and diagnostics. The company utilizes a proprietary Layer-by-Layer (LbL) assembly technique to develop functionalized nanocarriers designed for targeted therapy in oncology and neurodegenerative disorders. Their platform aims to improve the bioavailability and reduce the toxicity of existing therapeutic agents by ensuring precise delivery to diseased tissues. Mediteknology also provides specialized R&D services and collaborates with academic institutions to translate nanomedicine research into clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediteknology.